Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trialEllen M. Apperloo, Hiddo J.L. Heerspink, Josep M. Cruzado et al.|Nature Medicine|2024Cited by 95
Effects of Semaglutide on Kidney Parameters in Patients with Obesity and Nondiabetic CKDHiddo Jan L. Heerspink, José Luis Górriz, Ellen M. Apperloo et al.|Journal of the American Society of Nephrology|2024Cited by 0